SHR-A1811 for Injection Clinical Trials
4 recruitingDrug
Phase 32Phase 21Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Early-stage or Locally Advanced HER2-positive Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.740 enrolled2 locationsNCT07196774
Recruiting
Phase 1
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.107 enrolled1 locationNCT07275242
Recruiting
Phase 2
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Gastric CancerGastroesophageal-junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.200 enrolled2 locationsNCT07110571
Recruiting
Phase 3
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled2 locationsNCT07111832